Literature DB >> 31927437

Computational approaches in cancer multidrug resistance research: Identification of potential biomarkers, drug targets and drug-target interactions.

A Tolios1, J De Las Rivas2, E Hovig3, P Trouillas4, A Scorilas5, T Mohr6.   

Abstract

Like physics in the 19th century, biology and molecular biology in particular, has been fertilized and enhanced like few other scientific fields, by the incorporation of mathematical methods. In the last decades, a whole new scientific field, bioinformatics, has developed with an output of over 30,000 papers a year (Pubmed search using the keyword "bioinformatics"). Huge databases of mass throughput data have been established, with ArrayExpress alone containing more than 2.7 million assays (October 2019). Computational methods have become indispensable tools in molecular biology, particularly in one of the most challenging areas of cancer research, multidrug resistance (MDR). However, confronted with a plethora of different algorithms, approaches, and methods, the average researcher faces key questions: Which methods do exist? Which methods can be used to tackle the aims of a given study? Or, more generally, how do I use computational biology/bioinformatics to bolster my research? The current review is aimed at providing guidance to existing methods with relevance to MDR research. In particular, we provide an overview on: a) the identification of potential biomarkers using expression data; b) the prediction of treatment response by machine learning methods; c) the employment of network approaches to identify gene/protein regulatory networks and potential key players; d) the identification of drug-target interactions; e) the use of bipartite networks to identify multidrug targets; f) the identification of cellular subpopulations with the MDR phenotype; and, finally, g) the use of molecular modeling methods to guide and enhance drug discovery. This review shall serve as a guide through some of the basic concepts useful in MDR research. It shall give the reader some ideas about the possibilities in MDR research by using computational tools, and, finally, it shall provide a short overview of relevant literature.
Copyright © 2019. Published by Elsevier Ltd.

Entities:  

Keywords:  Cancer; Computational tools; In silico testing; Machine learning; Molecular simulations; Multi-omics expression data; Multidrug resistance; Network analysis

Year:  2019        PMID: 31927437     DOI: 10.1016/j.drup.2019.100662

Source DB:  PubMed          Journal:  Drug Resist Updat        ISSN: 1368-7646            Impact factor:   18.500


  13 in total

Review 1.  A comprehensive review on genomics, systems biology and structural biology approaches for combating antimicrobial resistance in ESKAPE pathogens: computational tools and recent advancements.

Authors:  P Priyamvada; Reetika Debroy; Anand Anbarasu; Sudha Ramaiah
Journal:  World J Microbiol Biotechnol       Date:  2022-07-05       Impact factor: 3.312

2.  Supervised Methods for Biomarker Detection from Microarray Experiments.

Authors:  Angela Serra; Luca Cattelani; Michele Fratello; Vittorio Fortino; Pia Anneli Sofia Kinaret; Dario Greco
Journal:  Methods Mol Biol       Date:  2022

3.  Transcriptomic profiling on localized gastric cancer identified CPLX1 as a gene promoting malignant phenotype of gastric cancer and a predictor of recurrence after surgery and subsequent chemotherapy.

Authors:  Haruyoshi Tanaka; Mitsuro Kanda; Dai Shimizu; Chie Tanaka; Yoshikuni Inokawa; Norifumi Hattori; Masamichi Hayashi; Goro Nakayama; Yasuhiro Kodera
Journal:  J Gastroenterol       Date:  2022-06-21       Impact factor: 6.772

4.  Improving Global Healthcare and Reducing Costs Using Second-Generation Artificial Intelligence-Based Digital Pills: A Market Disruptor.

Authors:  Yaron Ilan
Journal:  Int J Environ Res Public Health       Date:  2021-01-19       Impact factor: 3.390

Review 5.  Application of Artificial Intelligence Technology in Oncology: Towards the Establishment of Precision Medicine.

Authors:  Ryuji Hamamoto; Kruthi Suvarna; Masayoshi Yamada; Kazuma Kobayashi; Norio Shinkai; Mototaka Miyake; Masamichi Takahashi; Shunichi Jinnai; Ryo Shimoyama; Akira Sakai; Ken Takasawa; Amina Bolatkan; Kanto Shozu; Ai Dozen; Hidenori Machino; Satoshi Takahashi; Ken Asada; Masaaki Komatsu; Jun Sese; Syuzo Kaneko
Journal:  Cancers (Basel)       Date:  2020-11-26       Impact factor: 6.639

Review 6.  Targeting Endothelial Cell-Specific Molecule 1 Protein in Cancer: A Promising Therapeutic Approach.

Authors:  He Zhang; Yi-Wen Shen; Li-Jun Zhang; Jin-Jiao Chen; Hui-Ting Bian; Wen-Jie Gu; Hong Zhang; Hong-Zhuan Chen; Wei-Dong Zhang; Xin Luan
Journal:  Front Oncol       Date:  2021-05-24       Impact factor: 6.244

Review 7.  Multi-Omics Model Applied to Cancer Genetics.

Authors:  Francesco Pettini; Anna Visibelli; Vittoria Cicaloni; Daniele Iovinelli; Ottavia Spiga
Journal:  Int J Mol Sci       Date:  2021-05-27       Impact factor: 5.923

8.  Systems Biology Approaches to Understanding the Human Immune System.

Authors:  Bhavjinder K Dhillon; Maren Smith; Arjun Baghela; Amy H Y Lee; Robert E W Hancock
Journal:  Front Immunol       Date:  2020-07-30       Impact factor: 7.561

9.  Transcriptomics and Prognosis Analysis to Identify Critical Biomarkers in Invasive Breast Carcinoma.

Authors:  Jun Wu; Xiao-Jun Liu; Jia-Nan Hu; Xu-Hui Liao; Fei-Fei Lin
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec

Review 10.  Classifying the Linkage between Adipose Tissue Inflammation and Tumor Growth through Cancer-Associated Adipocytes.

Authors:  Yae Chan Song; Seung Eon Lee; Young Jin; Hyun Woo Park; Kyung-Hee Chun; Han-Woong Lee
Journal:  Mol Cells       Date:  2020-09-30       Impact factor: 5.034

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.